Navigation Links
Gauze-based NPWT Capable of Achieving Same Treatment Goals as Foam-based NPWT
Date:10/24/2009

th the U.S. Securities and Exchange Commission under the U.S. Securities Exchange Act of 1934, as amended, including Smith & Nephew's most recent annual report on Form 20F, for a discussion of certain of these factors.

All forward-looking statements in this press release are based on information available to Smith & Nephew as of the date hereof. All written or oral forward-looking statements attributable to Smith & Nephew or any person acting on behalf of Smith & Nephew are expressly qualified in their entirety by the foregoing. Smith & Nephew does not undertake any obligation to update or revise any forward-looking statement contained herein to reflect any change in Smith & Nephew's expectation with regard thereto or any change in events, conditions or circumstances on which any such statement is based.

SOURCE Smith & Nephew Inc.


'/>"/>
SOURCE Smith & Nephew Inc.
Copyright©2009 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3 4

Related medicine technology :

1. Study Shows Plasma-Derived Human Thrombin Equivalent to Bovine Thrombin in Achieving Hemostasis in Surgery
2. Cell Therapeutics Pixantrone Phase III (EXTEND) Pivotal Trial Successful in Achieving Primary Endpoint
3. CRESTOR(R) Reduced CV Risk in Patients Achieving Low LDL and hsCRP Targets in New JUPITER Analysis
4. Reclast(R) Receives US FDA Approval as First and Only Once-Yearly Treatment for Women With Postmenopausal Osteoporosis
5. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
6. The Multiple Myeloma Research Consortium (MMRC) and Proteolix Initiate Phase 2 Clinical Trial Investigating Carfilzomib for the Treatment of Multiple Myeloma
7. Millennium Initiates Clinical Trial to EVOLVE the Treatment of Patients with Newly Diagnosed Multiple Myeloma
8. Sixty-One Percent of Newly Diagnosed Parkinsons Disease Patients Do Not Receive Any Drug Treatment in the First Year of Diagnosis
9. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
10. TaiGen Biotechnology Successfully Completes Patient Recruitment for Phase II Trial of Nemonoxacin for Treatment of Adult Community Acquired Pneumonia (CAP)
11. Wyeths Torisel and Roche/Genentechs Avastin Will Challenge Pfizers Sutent to Become the Clinical Gold Standard for Treatment of Metastatic Renal Cell Carcinoma
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/16/2009)... 16 Today, Avantium announced the,appointment ... of its pharmaceutical,business. Gunnar Staaf previously worked ... Lilly & Company, in a range of ... important step in Avantium,s plan to,spin-out its ... a,stand-alone pharmaceutical company based on its offering ...
(Date:12/16/2009)... -- Vivakor, Inc. (OTC Bulletin Board: VIVK) ... Baker Consulting out of Walnut Creek, California ... out of South Florida. Baker Consulting ... with business development, financing and assisting the ... Specifically, Baker Consulting is exploring potential acquisition ...
(Date:12/16/2009)... Ill., Dec. 16 Naurex Inc., a ... depression and other CNS disorders based on its ... data presented at a major medical meeting showed ... and anxiolytic-like activity with no signs of the ... the NMDA receptor(1). The studies also showed ...
Breaking Medicine Technology:Avantium Appoints Gunnar Staaf as CEO Pharma 2Vivakor Signs Business Development Agreement With Baker Consulting 2Naurex Inc. Announces Presentation of Preclinical Data Showing its Novel Mechanism NMDA Modulator Exhibits Robust and Rapid-Onset Antidepressant Activity With No Signs of Classic NMDA-Associated Side Effects 2Naurex Inc. Announces Presentation of Preclinical Data Showing its Novel Mechanism NMDA Modulator Exhibits Robust and Rapid-Onset Antidepressant Activity With No Signs of Classic NMDA-Associated Side Effects 3Naurex Inc. Announces Presentation of Preclinical Data Showing its Novel Mechanism NMDA Modulator Exhibits Robust and Rapid-Onset Antidepressant Activity With No Signs of Classic NMDA-Associated Side Effects 4Naurex Inc. Announces Presentation of Preclinical Data Showing its Novel Mechanism NMDA Modulator Exhibits Robust and Rapid-Onset Antidepressant Activity With No Signs of Classic NMDA-Associated Side Effects 5Naurex Inc. Announces Presentation of Preclinical Data Showing its Novel Mechanism NMDA Modulator Exhibits Robust and Rapid-Onset Antidepressant Activity With No Signs of Classic NMDA-Associated Side Effects 6Cardinal Health Names Patricia Morrison Chief Information Officer 52643 1Cardinal Health Names Patricia Morrison Chief Information Officer 52643 2Dialysis Corporation of America Announces Second Quarter 2009 Earnings Release Date 52640 1Dialysis Corporation of America Announces Second Quarter 2009 Earnings Release Date 52640 2Are Patients Becoming Victims in Hospital Overcrowding Turf Wars 3F Experts Ask 52637 1Are Patients Becoming Victims in Hospital Overcrowding Turf Wars 3F Experts Ask 52637 2
(Date:12/16/2009)... NORCROSS, Ga., Dec. 16 Immucor, Inc. (Nasdaq: ... instrument-reagent systems to the blood transfusion industry, today announced ... its board as a new independent director, effective January ... in blood banking and transfusion medicine for more than ... and Medicine at the University of Virginia School of ...
(Date:12/16/2009)... most widely used human embryonic stem cell lines lack ... that must be addressed to ensure that all sectors ... a University of Michigan research team. ,, In the ... analyzed 47 embryonic stem cell lines, including most of ... scientists determined the genetic ancestry of each line and ...
(Date:12/16/2009)... seven that increase susceptibility to disease , , WEDNESDAY, ... with increased susceptibility to leprosy have been identified ... researchers, who analyzed more than 10,000 DNA samples ... said their discovery highlights the important role that ... of leprosy. , "Though leprosy is not common, ...
(Date:12/16/2009)... at work on a malaria elimination study in Africa ... the disease using cell phone records. , The scientists ... often residents of Zanzibar travel and where they go. ... coast of Tanzania in East Africa, Zanzibar has drastically ... study as part of deliberations on whether to launch ...
(Date:12/16/2009)... they cut bleeding time in half, but use in humans ... -- Hoping to improve on nature, researchers have built and ... be used in trauma or other cases where blood just ... with material that is used in degradable stitches, which dissolve ... biomedical engineering at Case Western Reserve University, and lead author ...
Breaking Medicine News(10 mins):Health News:Immucor Appoints New Board Director 2Health News:U-M Study Reveals Surprising Lack of Genetic Diversity in the Most Widely Used Human Embryonic Stem Cell Lines 2Health News:U-M Study Reveals Surprising Lack of Genetic Diversity in the Most Widely Used Human Embryonic Stem Cell Lines 3Health News:U-M Study Reveals Surprising Lack of Genetic Diversity in the Most Widely Used Human Embryonic Stem Cell Lines 4Health News:U-M Study Reveals Surprising Lack of Genetic Diversity in the Most Widely Used Human Embryonic Stem Cell Lines 5Health News:Leprosy Genes Identified 2Health News:Scientists use cell phone records to predict spread of malaria 2Health News:Scientists use cell phone records to predict spread of malaria 3Health News:Synthetic Platelets Put the Brakes on Blood Loss 2Health News:Synthetic Platelets Put the Brakes on Blood Loss 3
... May 15 (Nasdaq: WHRT, TSX:,WHT) World Heart ... 2008, it had received a NASDAQ Staff Determination ... on The NASDAQ Capital Market,has been denied. The ... a,definitive plan evidencing its ability to achieve near ...
... 15 The US-China Business,Council (USCBC) today encouraged ... way in China in response to the devastating ... USCBC member companies have already pledged several million ... aid to earthquake victims and many,have established matching ...
... a press release earlier this,year, the FDA issued a ... (OTC) cough and cold products should not,be used to ... age because,serious and potentially life-threatening side effects can occur ... and caregivers that OTC cough,and cold medicines not be ...
... in preliminary trial , , THURSDAY, May 15 (HealthDay ... a lower risk of the heart rhythm abnormality ... coronary disease. , "Our finding alone doesn,t prove ... supports the hypothesis that they may," said study ...
... on relationship marketing, SAN DIEGO, May 15 ... consumers to "Live Life to the Youngest" and,pursue ... younger, received,a Silver Award at the 2008 Pharmaceutical ... May 1, 2008. The,RealAge/ARD Marketing Valtrex(R) campaign was ...
... & 15 at Paris Las ... ... musical journey across America when Las Vegas-based HIV/AIDS,charity Golden Rainbow presents its ... 14 and 15 in Le,Theatre des Arts at Paris Las Vegas., ...
Other Medicine News:Health News:WorldHeart Announces Possible Delisting Action by NASDAQ 2Health News:WorldHeart Announces Possible Delisting Action by NASDAQ 3Health News:US Companies Aid Chinese Earthquake Victims 2Health News:US Companies Aid Chinese Earthquake Victims 3Health News:US Companies Aid Chinese Earthquake Victims 4Health News:US Companies Aid Chinese Earthquake Victims 5Health News:US Companies Aid Chinese Earthquake Victims 6Health News:US Companies Aid Chinese Earthquake Victims 7Health News:Saline is Safe Alternative to Harmful Cough and Cold Products 2Health News:Statins May Help Older Women Control Irregular Heartbeat 2Health News:RealAge Wins Silver PhAME Award 2Health News:Golden Rainbow Takes a Musical Journey for Its 22nd Annual 'Ribbon of Life' Production Show 2
... Microtome is ideal for sectioning of specimens in ... Specimen rise is automatic and accurate with section ... increments of 2 microns. Will accommodate MNL ... Vibratomes Freezing Stages , ...
... The Starter Package is a ... your laboratory. The package includes ... kit, additional mounting blocks, v-block ... and a rotating stage assembly ...
... Professional Package is the best ... laboratory. The package includes the ... additional mounting blocks, v-block adapter, ... a sapphire blade for the ...
... System provides a versatile means of sectioning ... The 1000 employs a vibrating blade ... embedding. The creation of artifacts, the ... activities, and other deleterious effects inherent in ...
Medicine Products: